Article Cited by others

ORIGINAL ARTICLE

Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer

Kang Ho Won, Jung Hae Do, Lee Joo Yong, Kwon Jong Kyou, Jeh Seong Uk, Cho Kang Su, Ham Won Sik, Choi Young Deuk

Year : 2016| Volume: 18| Issue : 3 | Page no: 480-484

   This article has been cited by
 
1 Up-regulation of LIMK1 expression in prostate cancer is correlated with poor pathological features, lymph node metastases and biochemical recurrence
Jin-Bei Huang,Yu-Peng Wu,Yun-Zhi Lin,Hai Cai,Shao-Hao Chen,Xiong-Lin Sun,Xiao-Dong Li,Yong Wei,Qing-Shui Zheng,Ning Xu,Xue-Yi Xue
Journal of Cellular and Molecular Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy
Masahiro Yashi,Akinori Nukui,Yuumi Tokura,Kohei Takei,Issei Suzuki,Kazumasa Sakamoto,Hideo Yuki,Tsunehito Kambara,Hironori Betsunoh,Hideyuki Abe,Yoshitatsu Fukabori,Yoshimasa Nakazato,Yasushi Kaji,Takao Kamai
BMC Urology. 2017; 17(1)
[Pubmed]  [Google Scholar] [DOI]
3 Long-term cancer control outcomes of robot-assisted radical prostatectomy for prostate cancer treatment: a meta-analysis
Lei Wang,Baojun Wang,Qing Ai,Yu Zhang,Xiangjun Lv,Hongzhao Li,Xin Ma,Xu Zhang
International Urology and Nephrology. 2017;
[Pubmed]  [Google Scholar] [DOI]
4 Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 23) and Implications for Risk Stratification: A Systematic Review
Christopher J. Kane,Scott E. Eggener,Alan W. Shindel,Gerald L. Andriole
European Urology Focus. 2017;
[Pubmed]  [Google Scholar] [DOI]
5 Reduced Connexin 43 expression is associated with tumor malignant behaviors and biochemical recurrence-free survival of prostate cancer
Ning Xu,Hui-Jun Chen,Shao-Hao Chen,Xue-Yi Xue,Hong Chen,Qing-Shui Zheng,Yong Wei,Xiao-Dong Li,Jin-Bei Huang,Hai Cai,Xiong-Lin Sun
Oncotarget. 2016; 7(41): 67476
[Pubmed]  [Google Scholar] [DOI]

 

Read this article